COVID-19 Resources

SRI is committed to bringing you the most current and relevant information as it relates to COVID-19.

Institute for Health Metrics and Evaluation - COVID-19 Projections

COVID-19 Open Research Dataset (CORD-19)

The Lancet Resource Centre

CDC - Cases in US

Handbook of COVID-19 Treatment and Prevention

Ethics of Precaution: Individual and Systemic Risk 

The CDC Guidance on Treatment of Patients with COVID-19

ACOG Guidance on Patient Management of COVID-19 
Provides an algorithm for evaluation and treatment of pregnant patients during the crisis. 

ASRM Guidance and Update for Management of Patients During the COVID-19 Pandemic

Interactive Map - Johns Hopkins

Coronavirus: Why You Must Act Now

Coronavirus: The Hammer and the Dance

Responding to Covid-19 — A Once-in-a-Century Pandemic? - Bill Gates

Coronavirus, Pregnancy, and IVF

SOGC Committee Opinion – COVID-19 in Pregnancy

Management of obstetrics and gynaecological patients with COVID-19
Franchi M, Bosco M, Garzon S, Laganà AS, Cromi A, Barbieri B, Raffaelli R, Tacconelli E, Scambia G, Ghezzi F. Management of obstetrics and gynaecological patients with COVID-19. It J Gynaecol Obstet. 2020;32(1):6-19.

Inositol and pulmonary function. Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2?
Bizzarri M, Laganà AS, Aragona D, Unfer V. Inositol and Pulmonary Function. Could Myo-Inositol Treatment Downregulate Inflammation and Cytokine Release Syndrome in SARS-CoV-2? Eur Rev Med Pharmacol Sci. 2020;24(6):3426-3432.

Coalition for Physician Accountability Statement on Safeguarding the Public and Health Care Workforce During COVID

Clinical Changes Due to COVID-19 Survey
The University of Cincinnati has published a survey titled "Clinical changes in Reproductive Medicine in light of the COVID-19 pandemic "aimed at assessing the preparedness and  practice changes that have been implemented by Reproductive Health practices. This has been IRB approved with IRB ID 2020-0353.  

The link can be found here:

PRIORITY (PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY
PRIORITY is a nationwide study of pregnant or recently pregnant women who are either under investigation for Coronavirus infection (COVID-19) or have been confirmed to have COVID-19. Women that are pregnant or have been pregnant within the last 6 weeks are eligible. This study is being done to help patients and doctors better understand how COVID-19 impacts pregnant women and their newborns.  Health care providers may refer their patients on the website, or women may self-refer.

Study Website:
Study email:
Phone: 415-476-2850

COVID-19 Fact Sheet (English)

COVID-19 Fact Sheet (Spanish)

COVID-19 Podcasts

Mother to Baby Podcast - COVID-19 in Pregnancy Breastfeeding

Mother to Baby Podcast - COVID-19 Pandemic Repercussions During Pregnancy Breastfeeding

COVID-19 Blog

Mother to Baby - COVID-19 Blog (English)

Mother to Baby - COVID-19 (Spanish)

COVID-19: the perspective of Italian embryologists managing the IVF laboratory in pandemic emergency
The epidemic in Italy started on January 30 and, following the spread of cases throughout the whole country, the Government declared the lockdown. In the field of reproductive medicine, this led to recommendations from the major scientific societies to suspend in vitro fertilization (IVF) treatments.


Society for Reproductive Investigation

since 1953

Cookie Notice

We use cookies to ensure you the best experience on our website. Your acceptance helps ensure that experience happens. To learn more, please visit our Privacy Notice.